Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunitybio Inc (NQ: IBRX ) 6.130 -0.270 (-4.22%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,347,413 Open 6.360 Bid (Size) 6.150 (2) Ask (Size) 6.160 (39) Prev. Close 6.400 Today's Range 6.065 - 6.360 52wk Range 1.250 - 10.53 Shares Outstanding 391,156,513 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Top Cancer Treatment Stocks to Buy Now July 17, 2024 These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term. Via InvestorPlace China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio? June 23, 2024 Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11%), RKLB (+11%), BFH (+10%), BRFS (+10%). Via Benzinga Performance YTD +16.98% +16.98% 1 Month +5.15% +5.15% 3 Month +16.98% +16.98% 6 Month +67.95% +67.95% 1 Year +106.40% +106.40% More News Read More Why ImmunityBio Stock Is Trading Higher Thursday June 20, 2024 Via Benzinga KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday June 20, 2024 Via Benzinga How Is The Market Feeling About ImmunityBio? May 17, 2024 Via Benzinga Check Out What Whales Are Doing With IBRX April 30, 2024 Via Benzinga Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors June 20, 2024 From ImmunityBio, Inc. Via Business Wire 3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions June 20, 2024 Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update June 07, 2024 From ImmunityBio, Inc. Via Business Wire These 3 Interesting Stocks Are Seeing Heavy Short Interest In June 2024 June 04, 2024 Via Talk Markets Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast May 17, 2024 From ImmunityBio, Inc. Via Business Wire Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months May 13, 2024 Via Talk Markets IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024 May 10, 2024 Via InvestorPlace The 3 Best Bargain Stocks to Buy in May 2024 May 09, 2024 Via InvestorPlace Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday May 07, 2024 Via Benzinga ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA® May 07, 2024 From ImmunityBio, Inc. Via Business Wire Even Worse than Gamestop? 3 Meme Stocks That Are Screaming Sells May 06, 2024 Via InvestorPlace Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy May 03, 2024 Via Benzinga Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday May 03, 2024 Via Benzinga ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types May 02, 2024 From ImmunityBio, Inc. Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session May 02, 2024 Via Benzinga ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to Discuss ANKTIVA® Approval in Fireside Chat at the Annual Conference of the American Urological Association April 30, 2024 From ImmunityBio, Inc. Via Business Wire Stocks Quietly Climb Ahead Of Central Bank Storm April 29, 2024 Via Talk Markets Topics Economy Stocks Exposures Interest Rates US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
